Updated recommendations on the management of gastrointestinal disturbances during iron chelation therapy with Deferasirox in transfusion dependent patients with myelodysplastic syndrome - Emphasis on optimized dosing schedules and new formulations / Nolte, F; Angelucci, E; Breccia, M; Gattermann, N; Santini, V; Vey, N; Hofmann, Wk. - In: LEUKEMIA RESEARCH. - ISSN 0145-2126. - 39:10(2015), pp. 1028-1033. [10.1016/j.leukres.2015.06.008]
Updated recommendations on the management of gastrointestinal disturbances during iron chelation therapy with Deferasirox in transfusion dependent patients with myelodysplastic syndrome - Emphasis on optimized dosing schedules and new formulations
Breccia M;
2015
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
